Wittenberg Investment Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
32,500
-1,000
-3% -$51.7K 0.78% 23
2026
Q1
$1.7M Hold
33,500
0.63% 27
2025
Q4
$988K Buy
+33,500
New +$910K 0.38% 41

Other funds holding MRNA

Wittenberg Investment Management's MRNA Position: Q2 2026 in Review

Wittenberg Investment Management reduced its Moderna (MRNA) stake by 3% in Q2 2026, selling an estimated $51.7K and leaving 32,500 shares worth $2.28M. The position accounts for 0.78% of the portfolio, ranked #23.

Wittenberg Investment Management first reported a position in MRNA in Q4 2025 and has held it in 3 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Wittenberg Investment Management held 32,500 shares of Moderna worth $2.28M as of Q2 2026.
  • Wittenberg Investment Management sold 1,000 Moderna shares in Q2 2026, an estimated $51.7K.
  • Moderna made up 0.78% of Wittenberg Investment Management's portfolio in Q2 2026, its #23 holding.
  • Wittenberg Investment Management first reported a position in Moderna in Q4 2025 and has held it in 3 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Wittenberg Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.